Allergic Rhinitis, Asthma and COPD Therapeutics Practice Test

These questions are part of the practice quiz. Start practicing

• Which statement accurately differentiates Formoterol and Salmeterol?
• What long-term adverse effect can result from prolonged use of oral corticosteroids?
• What is the most effective intervention to reduce the risk and progression of COPD?
• What adverse effect is commonly associated with intranasal antihistamines?
• Which of the following is NOT a non-drug therapy option for allergic rhinitis?
• A productive cough is typically associated with which condition?
• What can be a consequence of theophylline levels greater than 20 mcg/mL?
• Which of the following antihistamine classes can be used as monotherapy for allergic rhinitis?
• Which combination product includes Salmeterol and Fluticasone?
• What is a significant concern when using high doses of inhaled corticosteroids over the long term?
• In the context of asthma management, what does FEV1 measure?
• What should you mix with saline packets for nasal irrigation?
• What is a common cause of cough with variable productivity?
• When is the addition of azithromycin appropriate for COPD patients?
• How should group A COPD be treated?
• What type of cough is characterized as 'wet' or 'productive'?
• What treatment is preferred for patients experiencing asthma symptoms less than 3-5 days a week?
• What defines patient group B in COPD?
• What is an adverse drug reaction associated with short-term use of oral corticosteroids?
• What should patients be advised about using capsules with Handihaler and Neohaler?
• What is a significant adverse effect associated with Long-Acting Beta Agonists (LABAs)?
• Which medication is typically used during acute exacerbations of asthma?
• When should antibiotics be initiated in COPD exacerbations?
• When should expectorants be utilized in therapeutic practice?
• What is a common adverse reaction that may occur with leukotriene modifiers?
• How long may it take to see the effectiveness of intranasal steroids?
• What is the minimum duration for using immunotherapy to achieve the best effects?
• What is a common etiology for subacute cough?
• Which of the following conditions is likely to cause a non-productive cough?
• Which one of the following medications is commonly used for combination therapy in asthma treatment?
• What action should be taken regarding LABA when stepping down therapy?
• When are intranasal steroids recommended for allergic rhinitis?
• Which of the following statements about LABAs is true?
• What is the primary mechanism of action for inhaled corticosteroids?
• Is spirometry required for the diagnosis of COPD?
• What is the primary mechanism of action of decongestants in treating nasal congestion?
• When are oral leukotriene modifiers indicated in asthma therapy?
• Which of the following best describes an acute cough?
• Which strategy is important to employ before a step down in therapy?
• What is a common trigger for asthma exacerbations?
• How can a patient establish their personal best for peak flow monitoring?
• What condition should intranasal decongestants NOT be used for longer than 3 days due to rebound congestion?
• What is the correct way to use a metered dose inhaler for someone with coordination difficulties?
• What characterizes type 2 asthma disease process?
• What is the characteristic of patient group E in COPD?
• Which patient condition would indicate caution when prescribing LAMAs?
• What should patients avoid doing for 15 minutes after administering intranasal steroids?
• When should sustained step-up therapy be considered?
• What type of therapy does immunotherapy represent for allergies?
• What is a common comorbidity associated with type 2 asthma?
• What is the recommended follow-up treatment for predominant dyspnea in COPD?
• True or False: All COPD patients should receive a rescue short-acting bronchodilator.
• How does FEV1 influence the treatment of COPD patients?
• Which of the following is a common feature of type 2 asthma?
• How should inhalers be used in succession for asthma management?
• What characterizes patient group A for COPD?
• What is a potential benefit of using maintenance and reliever therapy with formoterol?
• Which of the following is a common brand name for dry powder inhalers?
• Which of the following indicates a need for increased therapy?
• Which of the following is a common adverse reaction for IL receptor antagonists?
• Which scale is preferred for assessing COPD symptoms based on multiple factors?
• Which of the following is a common adverse effect of intranasal antihistamines?
• What is a key factor to monitor when determining the need for a step up in therapy?
• What is a significant safety concern associated with breastfeeding women who are prescribed first generation antihistamines?
• Which condition is a primary etiology for chronic cough?
• Which of the following antihistamines is noted for potentially causing tachyphylaxis?
• What is the first step in the appropriate technique for using MDIs?
• On the CAT scale, what score indicates more symptoms in COPD?
• Which of the following is a common adverse drug reaction (ADR) of oral decongestants?
• Which of the following is a common counseling point for second generation antihistamines?
• Which of the following is a sign that a patient may require mechanical ventilation during a COPD exacerbation?
• Which of the following is a counseling point regarding Dupilumab?
• Which of the following is a common cause of COPD exacerbations?
• In asthma management, what is the preferred combination of Formoterol and ICS?
• When is oxygen therapy indicated in COPD patients?
• What route of administration is effective for administering intranasal antihistamines?
• What is the significance of spirometry in asthma management?
• How long can azithromycin be used chronically in COPD patients?
• What is a key characteristic of using dry powder inhalers (DPIs)?
• How long should antibiotic therapy be given in COPD exacerbations?
• What is the extent of use of montelukast in allergic rhinitis?
• How should symptoms of exacerbations be treated in COPD patients?
• What is the recommended action if a patient needs to use SABA more frequently?
• Which of the following indicates a high risk of exacerbations in COPD?
• What is a role of Cromolyn Sodium in asthma therapy?
• For sublingual (SL) immunotherapy, what is required for the first dose?
• Which medication is an example of a Long-Acting Muscarinic Antagonist (LAMA)?
• According to the Methamphetamine Epidemic Act of 2005, what is the maximum amount of pseudoephedrine that can be purchased in a 30-day period?
• What is the typical place of therapy for oral corticosteroids in asthma management?
• What should be done between puffs when using an MDI inhaler?
• In the context of COPD, what does "s/sx" refer to?
• What are the necessary precautions when administering subcutaneous (SQ) immunotherapy?
• What is a common adverse effect of intranasal decongestants?
• How can spirometry indicate a diagnosis of asthma?
• What symptom is typically associated with COPD exacerbations?
• For which of the following patient groups is the use of nebulizers most appropriate?
• What step of therapy is indicated for a patient diagnosed with asthma and an FEV1 of 58% predicted?
• Which of the following symptoms is NOT typically associated with asthma?
• What is the treatment approach for group E COPD?
• What triggers a cough related to gastroesophageal reflux disease (GERD)?
• Which lifestyle modification might be recommended for a patient with asthma?
• What symptoms are antihistamines particularly useful for treating in allergic rhinitis?
• What are some common brand names of metered dose inhalers (MDIs)?
• What does the presence of sputum purulence indicate in COPD exacerbations?
• Which statement about prolonged glucocorticoid treatment in COPD is correct?
• What role does eosinophil count play in COPD treatment decisions?
• What adverse effect is not typically associated with the use of second generation antihistamines?
• What is the mechanism of action (MOA) of intranasal cromolyn?
• What significant warning is associated with montelukast?
• What is the typical glucocorticoid dosage for COPD exacerbation treatment?
• What is the role of LAMAs in asthma management?
• Which factor is NOT recognized as a potential asthma trigger?
• Which of the following is a counseling point for mepolizumab?
• What is the primary focus in mMRC scoring?
• What does the CAT symptom scale for COPD evaluate?
• What is a crucial action when using a DPI inhaler?
• What is a known serious adverse effect of Montelukast?
• Which of the following is an example of a first generation antihistamine?
• Which of the following are common inhaled corticosteroids?
• What effect does pseudoephedrine typically have on blood pressure?
• What should be assessed before considering stepping up therapy?
• Which combination is typically used for the treatment of predominant dyspnea in COPD patients?
• What should be the patient's condition for stepping down therapy?
• What is the black box warning associated with codeine?
• What happens to the FEV1/FVC ratio after bronchodilator treatment in asthma?
• Which two intranasal steroids are preferred during pregnancy?
• What is the treatment for COPD primarily based on?
• Can you be allergic to a substance that your body has never encountered before?
• What counseling point should be highlighted for patients taking first generation antihistamines with regards to driving?
• Which condition indicates the need for antibiotic therapy during COPD exacerbations?
• When should spacers and valve holding chambers be utilized?
• What is an important technique for using a metered dose inhaler (MDI)?
• What type of therapy should be used during acute asthma exacerbations?
• What type of cough should dextromethorphan be used to suppress at night?
• Which medication class is typically initiated ASAP before discharge after a COPD exacerbation?
• Which of the following MDIs does NOT require shaking before use?
• Which mechanism of action describes how immunotherapy works in allergic rhinitis?
• Is there an age restriction on purchasing dextromethorphan in most states?
• What additional treatments can be considered for persistent symptoms in COPD?
• In step-down therapy for asthma management, by what percentage should the ICS dose typically be decreased?
• When should IL receptor antagonists be considered for asthma treatment?
• What is the best practice when a patient is ready to step down asthma therapy?
• Which of the following is an example of an oral decongestant?
• Is spirometry recommended for assessing COPD exacerbations?
• Which of the following is an example of an intranasal steroid?
• What is a significant warning associated with prolonged use of intranasal steroids?
• Which of the following is an example of a cough/cold combination product?
• When is immunotherapy most appropriately used for allergic rhinitis?
• What is a benefit of using nasal gels for allergic rhinitis?
• Which of the following second generation antihistamines requires caution in patients with a creatinine clearance less than 10?
• Using cough suppressants can assist with which of the following?
• Which of the following is an adverse reaction to intranasal steroids?
• When should de-escalation from ICS therapy be considered in COPD patients?
• Which medication should not be used in children under 10 years due to risks such as seizures?
• What key factor should be used to check for inhaler skills and adherence?
• When are cough suppressants indicated?
• You should NOT shake which of the following dry powder inhalers before use?
• Which of the following is a caution for the use of intranasal decongestants?
• What should be done if there is no relief from symptoms in COPD patients with eosinophil counts less than 300?
• How long must asthma be well-controlled before considering stepping down therapy?
• What is the positioning of Theophylline in asthma management?
• Which of the following substances can serve as a cough suppressant?
• What is a contraindication for the use of oral decongestants?
• What should be avoided in patients under 2 years or the elderly when considering first generation antihistamines?
• What is a significant adverse reaction associated with omalizumab?
• What is a key recommendation for health maintenance in patients with asthma?
• What is the main characteristic of asthma in relation to airflow?
• What is the primary treatment for group B COPD?
• What is the administration frequency for benralizumab after initial doses?
• What is a common adverse drug reaction associated with inhaled corticosteroids?
• What contraindication is associated with expectorants?
• What is the primary role of omalizumab in asthma therapy?
• What class of patients should avoid dextromethorphan usage?
• Which of the following is an example of an expectorant?
• What is a key consideration for theophylline therapy?
• Which of the following is NOT an FDA-approved immunotherapy agent?
• Which of the following is a short-term oral corticosteroid option for asthma?
• Which drug class is effective for treating red, itchy eyes due to allergic conjunctivitis?
• In what situation should intranasal cromolyn NOT be used?
• What is the recommended frequency for follow-ups in asthma management?
• On the mMRC symptom scale, what score indicates less symptoms in COPD?
• Which of the following is NOT a component of COPD exacerbation treatment?
• What should be monitored when administering Zileuton?
• How can peak flow measurements assist in asthma management?
• Which of the following is a component used to measure asthma control according to GINA?
• Is intranasal cromolyn suitable for use in children over 2 years of age?
• When should dry powder inhalers (DPIs) be used?
• True or False: Patients with asthma may not always demonstrate abnormal spirometry results.
• During day-to-day adjustments in therapy, what is recommended when using a combo ICS-formoterol inhaler?
• Which vaccinations are recommended for COPD patients?
• Which drug class does montelukast belong to?
• True or False: All patients benefit equally from inhaled corticosteroids.
• What is the standard approach for patients with moderate-severe allergic rhinitis symptoms?
• What is the primary use of intranasal ipratropium in allergic rhinitis?
• What is a less common cause of chronic cough?
• Which LABA can be combined with Budesonide in asthma therapy?
• Which of the following counseling points is recommended for patients using inhaled corticosteroids?
• Which of the following should be monitored for long-term management of asthma?
• Which of the following is NOT an adverse effect of LAMAs?
• What is the preferred bronchodilator treatment in COPD exacerbation?
• Which medication might be recommended for daily dosing in asthma management?
• In the context of COPD, what is typically assessed before prescribing treatment?
• What is one of the concerns associated with the use of first generation antihistamines?
• What is a potential adverse reaction to dextromethorphan?
• What is one of the actions of expectorants in the respiratory system?
• What is a recommended practice to improve the efficacy of nasal irrigation?
• In what situation should the ICS dose not be decreased when stepping down therapy?
• Who is considered at low risk for COPD exacerbations?
• Which of the following can be misused by minors, often resulting in euphoria?